AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$CBRS

Feldman Andrew D. sold $5.9M of CBRS

Feldman Andrew D. (CEO, President) sold 26,644 shares of Cerebras Systems Inc. (CBRS) at an average of $222.22 ($214.85–$240.01, $5.92M total) across 26 trades on 2026-08-18.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Aug 20, 2026, 1:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The CEO's reduction of ownership may be interpreted as a lack of confidence, prompting short‑term selling pressure.

02

Market read

Insider sell of $5.9 M by the CEO is a material event for CBRS, offering a modest bearish signal for traders.

03

What to watch

Potential upcoming capital raise or strategic shift not disclosed; the sale may free cash for future initiatives.

Relevance 6/10Novelty 7/10Timing: post‑market filing on 2026‑08‑18

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of corporate insider activity.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CEO Andrew Feldman sold 26,644 shares for $5.9 M via a Form 4 filing, reducing his stake to 66,853 shares.

Expected impact

Modest short‑term price dip, likely 1‑2% decline if market reacts.

Evidence & confidence

A $5.9 M sale by the CEO is material but not large enough to trigger a sharp move; investors may view it as a neutral signal.

Market effects

Sector

Minimal impact on the AI‑hardware sector; peers unlikely to be affected.

Regional

U.S. market only; no broader regional effect.

Global

Low; the filing is company‑specific.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to fundamentals, so price may remain stable.

Key entities

  • company
    Cerebras Systems Inc.

    AI‑chip maker listed on Nasdaq (CBRS).

  • person
    Andrew D. Feldman

    CEO and President of Cerebras Systems.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

finance.yahoo.com
$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

investing.com
$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

finance.yahoo.com
$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

finance.yahoo.com
$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.

finance.yahoo.com